Antibody recognition of chlamydia LPS: Structural insights of inherited immune responses

Anticarbohydrate Antibodies: From Molecular Basis to Clinical Application

Volumn 9783709108703, Issue , 2012, Pages 75-120

  Blackler, Ryan J ^a   Müller Loennies, Sven ^b   Brade, Lore ^b   Kosma, Paul ^c   Brade, Helmut ^b   Evans, Stephen V ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

^b RESEARCH CENTER BORSTEL   (Germany)

^c UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84899580407     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7091-0870-3_4     Document Type: Chapter

References (216)

1. Abhinandan KR, Martin ACR. (2008). Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains. Mol Immunol 45: 3832-3839
2. Adderson EE, Shackelford PG, Quinn A, Carroll WL. (1991). Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide. J Immunol 147: 1667-1674
3. Ahuja KK. (1982). Fertilization studies in the hamster: the role of cell-surface carbohydrates. Exp Cell Res 140: 353-362
4. Albert LJ, Inman RD. (1999). Molecular mimicry and autoimmunity. N Engl J Med 341: 2068
5. Al-Lazikani B, Lesk AM, Chothia C. (1997). Standard conformations for the canonical structures of immunoglobulins. J Mol Biol 273: 927-948
6. Al-Lazikani B, Lesk AM, Chothia C. (2000). Canonical structures for the hypervariable regions of T cell ab receptors. J Mol Biol 295: 979-995
7. Allcorn LC, Martin ACR. (2002). SACS - self-maintaining database of antibody crystal structure information. Bioinformatics 18: 175-181
8. Alt FW, Baltimore D. (1982). Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions. Proc Natl Acad Sci USA 79: 4118-4122
9. Astronomo RD, Burton DR. (2010). Carbohydrate vaccines: developing sweet solutions to sticky situations?. Nat Rev Drug Discov 9: 308-324
10. Avci FY, Kasper DL. (2010). How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol 28: 107-130
11. Babor M, Kortemme T. (2009). Multi constraint computational design suggests that native sequences of germline antibody H3 loops are nearly optimal for conformational flexibility. Proteins 75: 846-858
12. Benz I, Schmidt MA. (2002). Never say never again: protein glycosylation in pathogenic bacteria. Mol Microbiol 45: 267-276
13. Berry JD, Boese DJ, Law DK, Zollinger WD, Tsang RS. (2005). Molecular analysis of monoclonal antibodies to group variant capsular polysaccharide of Neisseria meningitidis: recurrent heavy chains and alternative light chain partners. Mol Immunol 42: 335-344
14. Bhavsar AP, Guttman JA, Finlay BB. (2007). Manipulation of host-cell pathways by bacterial pathogens. Nature 449: 827-834
15. Bock K, Thomsen JU, Kosma P, Christian R, Holst O, Brade H. (1992). A nuclear magnetic resonance spectroscopic investigation of Kdo-containing oligosaccharides related to the genus-specific epitope of Chlamydia lipopolysaccharides. Carbohydr Res 229: 213-224
16. Bonilla FA, Oettgen HC. (2010). Adaptive immunity. J Allergy Clin Immunol 125: S33-S40
17. Brabetz W, Müller-Loennies S, Holst O, Brade H. (1997). Deletion of the heptosyltransferase genes rfaC and rfaF in Escherichia coli K-12 results in an Re-type lipopolysaccharide with a high degree of 2-aminoethanol phosphate substitution. Eur J Biochem 247: 716-724
18. Brade H, Brade L, Nano FE. (1987). Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. Proc Natl Acad Sci USA 84: 2508-2512
19. Brade L, Rozalski A, Kosma P, Brade H. (2000). A monoclonal antibody recognizing the 3-deoxy-Dmanno- oct-2-ulosonic acid (Kdo) trisaccharide Kdo (24) Kdo (24) Kdo of Chlamydophila psittaci 6BC lipopolysaccharide. J Endotoxin Res 6: 361-368
20. Brade L, Gronow S, Wimmer N, Kosma P, Brade H. (2002). Monoclonal antibodies against 3- deoxy-a-D-manno-oct-2-ulosonic acid (Kdo) and D-glycero-a-D-talo-oct-2-ulosonic acid (Ko). J Endotoxin Res 8: 357-364
21. Brandley BK, Schnaar RL. (1986). Cell-surface carbohydrates in cell recognition and response. J Leukoc Biol 40: 97-111
22. Brochet X, Lefranc MP, Giudicelli V. (2008). IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 36: W503-W508
23. Brooks CL, Blackler RJ, Gerstenbruch S, Kosma P, Müller-Loennies S, Brade H, Evans SV (2008a) Pseudo-symmetry and twinning in crystals of homologous antibody Fv fragments. Acta Crystallogr D Biol Crystallogr 64: 1250-1258
24. Brooks CL, Müller-Loennies S, Brade L, Kosma P, Hirama T, MacKenzie CR, Brade H, Evans SV (2008b) Exploration of specificity in germline monoclonal antibody recognition of a range of natural and synthetic epitopes. J Mol Biol 377: 450-468
25. Brooks CL, Blackler RJ, Sixta G, Kosma P, Müller-Loennies S, Brade L, Hirama T, MacKenzie CR, Brade H, Evans SV (2010a) The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen. Glycobiology 20: 138-147
26. Brooks CL, Müller-Loennies S, Borisova SN, Brade L, Kosma P, Hirama T, Mackenzie CR, Brade H, Evans SV (2010b) Antibodies raised against chlamydial lipopolysaccharide antigens reveal convergence in germline gene usage and differential epitope recognition. Biochemistry 49: 570-581
27. Bucior I, Burger MM. (2004). Carbohydrate-carbohydrate interactions in cell recognition. Curr Opin Struct Biol 14: 631-637
28. Bundle DR, Young NM. (1992). Carbohydrate-protein interactions in antibodies and lectins. Curr Opin Struct Biol 2: 666-673
29. Bundle DR, Eichler E, Gidney MA, Meldal M, Ragauskas A, Sigurskjold BW, Sinnott B, Watson DC, Yaguchi M, Young NM. (1994). Molecular recognition of a Salmonella trisaccharide epitope by monoclonal antibody Se155-4. Biochemistry 33: 5172-5182
30. Buskas T, Thompson P, Boons GJ. (2009). Immunotherapy for cancer: synthetic carbohydratebased vaccines. Chem Commun 36: 5335-5349
31. Calarese DA, Scanlan CN, Zwick MB, Deechongkit S, Mimura Y, Kunert R, Zhu P, Wormald MR, Stanfield RL, Roux KH. (2003). Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300: 2065-2071
32. Calarese DA, Lee HK, Huang CY, Best MD, Astronomo RD, Stanfield RL, Katinger H, Burton DR, Wong CH, Wilson IA. (2005). Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. Proc Natl Acad Sci USA 102: 13372-13377
33. Cao Z, Zhao Z, Mohan R, Alroy J, Stanley P, Panjwani N. (2001). Role of the Lewis x glycan determinant in corneal epithelial cell adhesion and differentiation. J Biol Chem 276: 21714-21723
34. Casadevall A, Scharff MD. (1991). The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. J Exp Med 174: 151-160
35. Casadevall A, Mukherjee J, Devi SJ, Schneerson R, Robbins JB, Scharff MD. (1992). Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis 165: 1086-1093
36. Ceppellini R, Dray S, Edelman G, Fahey J, Franek F, Franklin E, Goodman HC, Grabar P, Gurvich AE, Heremans JF. (1964). Nomenclature for human immunoglobulins. Immunochemistry 1: 145-149
37. Chaudhuri J, Alt FW. (2004). Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat Rev Immunol 4: 541-552
38. Chothia C, Lesk AM. (1987). Canonical structures for the hypervariable regions of immunoglobulins. J Mol Biol 196: 901-917
39. Chothia C, Lesk AM, Gherardi E, Tomlinson IM, Walter G, Marks JD, Llewelyn MB, Winter G. (1992). Structural repertoire of the human VH segments. J Mol Biol 227: 799-817
40. Cohen IR. (2007). Biomarkers, self-antigens and the immunological homunculus. J Autoimmun 29: 246-249
41. Collot M, Wilson IB, Bublin M, Hoffmann-Sommergruber K, Mallet JM. (2010). Synthesis of cross-reactive carbohydrate determinants fragments as tools for in vitro allergy diagnosis. Bioorg Med Chem 19: 1306-1320
42. Cook GP, Tomlinson IM. (1995). The human immunoglobulin VH repertoire. Immunol Today 16: 237-242
43. Cordero RJ, Frases S, Guimaraes AJ, Rivera J, Casadevall A. (2011). Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity. Mol Microbiol 79 (4): 1101-1117
44. Cygler M, Rose DR, Bundle DR. (1991). Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science 253: 442-445
45. Danishefsky SJ, Allen JR. (2000). From the laboratory to the clinic: a retrospective on fully synthetic carbohydrate-based anticancer vaccines. Angew Chem Int Ed Engl 39: 836-863
46. Davies DR, Padlan EA, Sheriff S. (1990). Antibody-antigen complexes. Annu Rev Biochem 59: 439-473
47. Davies DR, Cohen GH. (1996). Interactions of protein antigens with antibodies. Proc Natl Acad Sci USA 93: 7-12
48. De Geus DC, van Roon AM, Thomassen EA, Hokke CH, Deelder AM, Abrahams JP. (2009). Characterization of a diagnostic Fab fragment binding trimeric Lewis X. Proteins 76: 439-447
49. Debler EW, Kaufmann GF, Kirchdoerfer RN, Mee JM, Janda KD, Wilson IA. (2007). Crystal structures of a quorum-quenching antibody. J Mol Biol 368: 1392-1402
50. Decanniere K, Desmyter A, Lauwereys M, Ghahroudi MA, Muyldermans S, Wyns L. (1999). A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops. Structure 7: 361-370
51. Decanniere K, Muyldermans S, Wyns L. (2000). Canonical antigen-binding loop structures in immunoglobulins: more structures, more canonical classes?. J Mol Biol 300: 83-91
52. Dudley DD, Chaudhuri J, Bassing CH, Alt FW. (2005). Mechanism and control of V (D) J recombination versus class switch recombination: similarities and differences. Adv Immunol 86: 43-112
53. Ebo DG, Hagendorens MM, Bridts CH. (2004). Sensitization to cross reactive carbohydrate determinants and the ubiquitous protein profilin: mimickers of allergy. Clin Exp Allergy 34: 137-144
54. Edelman GM. (1959). Dissociation of g-globulin. J Am Chem Soc 81: 3155-3156
55. Edelman GM, Poulik MD. (1961). Studies on structural units of the g-globulins. J Exp Med 113: 861-884
56. Edelman GM. (1991). Antibody structure and molecular immunology. Scand J Immunol 34: 4-22
57. Evans DW, Müller-Loennies S, Brooks CL, Brade L, Kosma P, Brade H, Evans SV. (2011). Structural insights into parallel strategies for germline antibody recognition of lipopolysaccharide from Chlamydia. Glycobiology 21 (8): 1049-1059
58. Favre M, Moehle K, Jiang L, Pfeiffer B, Robinson JA. (1999). Structural mimicry of canonical conformations in antibody hypervariable loops using cyclic peptides containing a heterochiral diproline template. J Am Chem Soc 121: 2679-2685
59. Fenderson BA, O'Brien DA, Millette CF, Eddy EM. (1984). Stage-specific expression of three cell surface carbohydrate antigens during murine spermatogenesis detected with monoclonal antibodies. Dev Biol 103: 117-128
60. Figueroa JE, Densen P. (1991). Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4: 359-395
61. Fleischman JB, Porter RR, Press EM. (1963). The arrangement of the peptide chains in g-globulin. Biochem J 88: 220-228
62. Foetisch K, Westphal S, Lauer I, Retzek M, Altmann F, Kolarich D, Scheurer S, Vieths S. (2003). Biological activity of IgE specific for cross-reactive carbohydrate determinants. J Allergy Clin Immunol 111: 889-896
63. Foote J, Milstein C. (1994). Conformational isomerism and the diversity of antibodies. Proc Natl Acad Sci USA 91: 10370-10374
64. Freire T, Bay S, Vichier-Guerre S, Lo-Man R, Leclerc C. (2006). Carbohydrate antigens: synthesis aspects and immunological applications in cancer. Mini Rev Med Chem 6: 1357-1373
65. Fukuda M. (1996). Possible roles of tumor-associated carbohydrate antigens. Cancer Res 56: 2237-2244
66. Fukuda MN, Akama TO. (2004). The role of N-glycans in spermatogenesis. Cytogenet Genome Res 103: 302-306
67. Fung P, Madej M, Koganty RR, Longenecker BM. (1990). Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate. Cancer Res 50: 4308-4314
68. Gearhart PJ. (1982). Generation of immunoglobulin variable gene diversity. Immunol Today 3: 107-112
69. Gerstenbruch S, Brooks CL, Kosma P, Brade L, MacKenzie CR, Evans SV, Brade H, Müller- Loennies S. (2010). Analysis of cross-reactive and specific anti-carbohydrate antibodies against lipopolysaccharide from Chlamydophila psittaci. Glycobiology 20: 461-472
70. Glabe CG, Grabel LB, Vacquier VD, Rosen SD. (1982). Carbohydrate specificity of sea urchin sperm binding: a cell surface lectin mediating sperm-egg adhesion. J Cell Biol 94: 123-128
71. Guarné A, Bravo J, Calvo J, Lozano F, Vives J, Fita I. (1996). Conformation of the hypervariable region L3 without the key proline residue. Protein Sci 5: 167-169
72. Guttormsen HK, Wetzler LM, Finberg RW, Kasper DL. (1998). Immunologic memory induced by a glycoconjugate vaccine in a murine adoptive lymphocyte transfer model. Infect Immun 66: 2026-2032
73. Hakomori S. (1984). Tumor-associated carbohydrate antigens. Annu Rev Immunol 2: 103-126
74. Hakomori S. (1989). Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 52: 257-331
75. Hakomori S. (1991). Possible functions of tumor-associated carbohydrate antigens. Curr Opin Immunol 3: 646-653
76. Hakomori S. (2001). Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines. Adv Exp Med Biol 491: 369-402
77. Han S, Zheng B, Dal Porto J, Kelsoe G. (1995). In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl) acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance. J Exp Med 182: 1635-1644
78. Harmsen MM, Ruuls RC, Nijman IJ, Niewold TA, Frenken LGJ, De Geus B. (2000). Llama heavychain V regions consist of at least four distinct subfamilies revealing novel sequence features. Mol Immunol 37: 579-590
79. Haselhorst T, Espinosa JF, Jimenez-Barbero J, Sokolowski T, Kosma P, Brade H, Brade L, Peters T. (1999). NMR experiments reveal distinct antibody-bound conformations of a synthetic disaccharide representing a general structural element of bacterial lipopolysaccharide epitopes. Biochemistry 38: 6449-6459
80. Haslam SM, Gems D, Morris HR, Dell A. (2002). The glycomes of Caenorhabditis elegans and other model organisms. Biochem Soc Symp 69: 117-134
81. Hecht ML, Stallforth P, Silva DV, Adibekian A, Seeberger PH. (2009). Recent advances in carbohydrate-based vaccines. Curr Opin Chem Biol 13: 354-359
82. Heine H, Müller Loennies S, Brade L, Lindner B, Brade H. (2003). Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC. Eur J Biochem 270: 440-450
83. Hemmer W, Focke M, Kolarich D, Wilson IBH, Altmann F, Wöhrl S, Götz M, Jarisch R. (2001). Antibody binding to venom carbohydrates is a frequent cause for double positivity to honeybee and yellow jacket venom in patients with stinging-insect allergy. J Allergy Clin Immunol 108: 1045-1052
84. Holmgren J, Lindholm L, Persson B, Lagergård T, Nilsson O, Svennerholm L, Rudenstam CM, Unsgaard B, Yngvason F, Pettersson S. (1984). Detection by monoclonal antibody of carbohydrate antigen CA 50 in serum of patients with carcinoma. Br Med J (Clin Res Ed) 288: 1479-1482
85. Holst O, Bock K, Brade L, Brade H. (1995). The structures of oligosaccharide bisphosphates isolated from the lipopolysaccharide of a recombinant Escherichia coli strain expressing the gene gseA [3-deoxy-D-manno-octulopyranosonic acid (Kdo) transferase] of Chlamydia psittaci 6BC. Eur J Biochem 229: 194-200
86. Iivanainen E, Kähäri VM, Heino J, Elenius K. (2003). Endothelial cell-matrix interactions. Microsc Res Tech 60: 13-22
87. Isshiki Y, Kawahara K, Zähringer U. (1998). Isolation and characterisation of disodium (4-amino-4- deoxy-b-L-arabinopyranosyl) - (18) - (D-glycero-a-D-talo-oct-2-ulopyranosylonate) - (24) - (methyl 3-deoxy-D-manno-oct-2-ulopyranosid) onate from the lipopolysaccharide of Burkholderia cepacia. Carbohydr Res 313: 21-27
88. Jacob J, Kelsoe G, Rajewsky K, Weiss U. (1991). Intraclonal generation of antibody mutants in germinal centres. Nature 354: 389-392
89. James LC, Tawfik DS. (2003). Conformational diversity and protein evolution - a 60-year-old hypothesis revisited. Trends Biochem Sci 28: 361-368
90. James LC, Roversi P, Tawfik DS. (2003). Antibody multispecificity mediated by conformational diversity. Science 299: 1362-1367
91. Janeway CA, Travers P, Walport M, Capra JD. (2001). Immunobiology: the immune system in health and disease, 5th edn. Garland Science, New York
92. Jeffrey PD, Bajorath J, Chang CYY, Yelton D, Hellström I, Hellström KE, Sheriff S. (1995). The X-ray structure of an anti-tumour antibody in complex with antigen. Nat Struct Mol Biol 2: 466-471
93. Jiménez R, Salazar G, Yin J, Joo T, Romesberg FE. (2004). Protein dynamics and the immunological evolution of molecular recognition. Proc Natl Acad Sci USA 101: 3803-3808
94. Jiménez D, Roda-Navarro P, Springer TA, Casasnovas JM. (2005). Contribution of N-linked glycans to the conformation and function of intercellular adhesion molecules (ICAMs). J Biol Chem 280: 5854-5861
95. Joziasse DH. (1992). Mammalian glycosyltransferases: genomic organization and protein structure. Glycobiology 2: 271-277
96. Kabat EA. (1956). Blood group substances: their chemistry and immunochemistry. Academic, New York
97. Kabat EA, Wu TT, Bilofsky H. (1977). Unusual distributions of amino acids in complementaritydetermining (hypervariable) segments of heavy and light chains of immunoglobulins and their possible roles in specificity of antibody-combining sites. J Biol Chem 252: 6609-6616
98. Kaltner H, Stierstorfer B. (2000). Animal lectins as cell adhesion molecules. Cells Tissues Organs 161: 162-179
99. Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. (2004). Carbohydrate mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci 95: 377-384
100. Kansas GS, Ley K, Munro JM, Tedder TF. (1993). Regulation of leukocyte rolling and adhesion to high endothelial venules through the cytoplasmic domain of L-selectin. J Exp Med 177: 833-838
101. Kawahara K, Brade H, Rietschel ET, Zähringer U. (1987). Studies on the chemical structure of the core-lipid A region of the lipopolysaccharide of Acinetobacter calcoaceticus NCTC 10305. Detection of a new 2-octulosonic acid interlinking the core oligosaccharide and lipid A component. Eur J Biochem 163: 489-495
102. Kindt TJ, Goldsby RA, Osborne BA, Kuby J. (2007). Kuby immunology, 6th edn. W.H. Freeman, New York
103. Klena JD, Pradel E, Schnaitman CA. (1993). The rfaS gene, which is involved in production of a rough form of lipopolysaccharide core in Escherichia coli K-12, is not present in the rfa cluster of Salmonella typhimurium LT2. J Bacteriol 175: 1524-1527
104. Kochi SK, Johnson RC, Dalmasso AP. (1991). Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. J Immunol 146: 3964-3970
105. Kosma P, Schulz G, Brade H. (1988). Synthesis of a trisaccharide of 3-deoxy-D-manno-2-octulopyranosylonic acid (KDO) residues related to the genus-specific lipopolysaccharide epitope of Chlamydia. Carbohydr Res 183: 183-199
106. Kosma P, Schulz G, Unger FM, Brade H. (1989). Synthesis of trisaccharides containing 3-deoxy- D-manno-2-octulosonic acid residues related to the KDO-region of enterobacterial lipopolysaccharides. Carbohydr Res 190: 191-201
107. Kosma P, Bahnmüller R, Schulz G, Brade H. (1990). Synthesis of a tetrasaccharide of the genus-specific lipopolysaccharide epitope of Chlamydia. Carbohydr Res 208: 37-50
108. Kosma P, Reiter A, Zamyatina A, Wimmer N, Glück A, Brade H. (1999). Synthesis of inner core antigens related to Chlamydia, Pseudomonas and Acinetobacter LPS. J Endotoxin Res 5: 157-163
109. Kosma P, Reiter A, Hofinger A, Brade L, Brade H. (2000). Synthesis of neoglycoproteins containing Kdo epitopes specific for Chlamydophila psittaci lipopolysaccharide. J Endotoxin Res 6: 57-69
110. Kosma P, Brade H, Evans SV. (2008). Lipopolysaccharide antigens of Chlamydia. In: ACS symposium series. ACS Publications, pp 239-257
111. Kudryashov V, Glunz PW, Williams LJ, Hintermann S, Danishefsky SJ, Lloyd KO. (2001). Toward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis y conjugates in mice. Proc Natl Acad Sci USA 98: 3264-3269
112. Kuroda D, Shirai H, Kobori M, Nakamura H. (2009). Systematic classification of CDR L3 in antibodies: implications of the light chain subtypes and the VL-VH interface. Proteins 75: 139-146
113. Landsteiner K. (1990). The specificity of serological reactions. Dover Publications, New York
114. Lang KS, Burow A, Kurrer M, Lang PA, Recher M. (2007). The role of the innate immune response in autoimmune disease. J Autoimmun 29: 206-212
115. Levinson SS. (1992). Antibody multispecificity in immunoassay interference. Clin Biochem 25: 77-87
116. Ley K, Gaehtgens P, Fennie C, Singer MS, Lasky LA, Rosen SD. (1991). Lectin-like cell adhesion molecule 1 mediates leukocyte rolling in mesenteric venules in vivo. Blood 77: 2553-2555
117. Li Z, Woo CJ, Iglesias-Ussel MD, Ronai D, Scharff MD. (2004). The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev 18 (1): 1-11
118. Lo-Man R, Vichier-Guerre S, Perraut R, Dériaud E, Huteau V, BenMohamed L, Diop OM, Livingston PO, Bay S, Leclerc C. (2004). A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Cancer Res 64: 4987-4994
119. Lucas AH, Moulton KD, Tang VR, Reason DC. (2001). Combinatorial library cloning of human antibodies to Streptococcus pneumoniae capsular polysaccharides: variable region primary structures and evidence for somatic mutation of Fab fragments specific for capsular serotypes 6B, 14, and 23 F. Infect Immun 69: 853-864
120. Lüderitz O, Freudenberg MA, Galanos C, Lehmann V, Rietschel ET, Shaw DH. (1982). Lipopolysaccharides of gram-negative bacteria. Curr Top Membr Transp 17: 79-151
121. Lutz HU. (2007). Homeostatic roles of naturally occurring antibodies: an overview. J Autoimmun 29: 287-294
122. Maaheimo H, Kosma P, Brade L, Brade H, Peters T. (2000). Mapping the binding of synthetic disaccharides representing epitopes of chlamydial lipopolysaccharide to antibodies with NMR. Biochemistry 39: 12778-12788
123. MacLean GD, Bowen-Yacyshyn MB, Samuel J, Meikle A, Stuart G, Nation J, Poppema S, Jerry M, Koganty R, Wong T. (1992). Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen-Friedenreich) determinant using a synthetic carbohydrate antigen. J Immunother 11: 292-305
124. MacLean GD, Reddish M, Koganty RR, Wong T, Gandhi S, Smolenski M, Samuel J, Nabholtz JM, Longenecker BM. (1993). Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant. Cancer Immunol Immunother 36: 215-222
125. Madri JA, Pratt BM. (1986). Endothelial cell-matrix interactions: in vitro models of angiogenesis. J Histochem Cytochem 34: 85-91
126. Manimala JC, Li Z, Jain A, VedBrat S, Gildersleeve JC. (2005). Carbohydrate array analysis of anti Tn antibodies and lectins reveals unexpected specificities: implications for diagnostic and vaccine development. Chembiochem 6: 2229-2241
127. Manis JP, Tian M, Alt FW. (2002). Mechanism and control of class-switch recombination. Trends Immunol 23: 31-39
128. Manivel V, Sahoo NC, Salunke DM, Rao KV. (2000). Maturation of an antibody response is governed by modulations in flexibility of the antigen-combining site. Immunity 13: 611-620
129. Manivel V, Bayiroglu F, Siddiqui Z, Salunke DM, Rao KV. (2002). The primary antibody repertoire represents a linked network of degenerate antigen specificities. J Immunol 169: 888-897
130. Marchalonis JJ, Adelman MK, Robey IF, Schluter SF, Edmundson AB. (2001). Exquisite specificity and peptide epitope recognition promiscuity, properties shared by antibodies from sharks to humans. J Mol Recognit 14: 110-121
131. Mari A, Iacovacci P, Afferni C, Barletta B, Tinghino R, Di Felice G, Pini C. (1999). Specific IgE to cross-reactive carbohydrate determinants strongly affect the in vitro diagnosis of allergic diseases. J Allergy Clin Immunol 103: 1005-1011
132. Melamed D, Nemazee D. (1997). Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc Natl Acad Sci USA 94: 9267-9272
133. Misevic GN, Burger MM. (1993). Carbohydrate-carbohydrate interactions of a novel acidic glycan can mediate sponge cell adhesion. J Biol Chem 268: 4922-4929
134. Mond JJ, Lees A, Snapper CM (1995a) T cell-independent antigens type 2. Annu Rev Immunol 13: 655-692
135. Mond JJ, Vos Q, Lees A, Snapper CM (1995b) T cell independent antigens. Curr Opin Immunol 7: 349-354
136. Morea V, Tramontano A, Rustici M, Chothia C, Lesk AM. (1998). Conformations of the third hypervariable region in the VH domain of immunoglobulins. J Mol Biol 275: 269-294
137. Müller R, Brade H, Kosma P. (1997). Synthesis of deoxy analogues of (28) -linked 3-deoxy-a-Dmanno- oct-2-ulopyranosylonic acid (Kdo) disaccharides for binding studies with Chlamydia specific monoclonal antibodies. J Endotoxin Res 4: 347-355
138. Müller-Eberhard HJ. (1984). The membrane attack complex. Springer Semin Immunopathol 7: 93-141
139. Müller-Loennies S, MacKenzie CR, Patenaude SI, Evans SV, Kosma P, Brade H, Brade L, Narang S. (2000). Characterization of high affinity monoclonal antibodies specific for chlamydial lipopolysaccharide. Glycobiology 10: 121-130
140. Müller-Loennies S, Grimmecke D, Brade L, Lindner B, Kosma P, Brade H. (2002). A novel strategy for the synthesis of neoglycoconjugates from deacylated deep rough lipopolysaccharides. J Endotoxin Res 8: 295-305
141. Müller-Loennies S, Gronow S, Brade L, MacKenzie R, Kosma P, Brade H. (2006). A monoclonal antibody against a carbohydrate epitope in lipopolysaccharide differentiates Chlamydophila psittaci from Chlamydophila pecorum, Chlamydophila pneumoniae, and Chlamydia trachomatis. Glycobiology 16: 184-196
142. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. (2000). Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID) , a potential RNA editing enzyme. Cell 102: 553-563
143. Murase T, Zheng RB, Joe M, Bai Y, Marcus SL, Lowary TL, Ng KK. (2009). Structural insights into antibody recognition of mycobacterial polysaccharides. J Mol Biol 392: 381-392
144. Nakouzi A, Casadevall A. (2003). The function of conserved amino acids in or near the complementarity determining regions for related antibodies to Cryptococcus neoformans glucuronoxylomannan. Mol Immunol 40: 351-361
145. Narayanan S. (2000). Molecular mimicry: basis for autoimmunity. Indian J Clin Biochem 15: 78-82
146. Nguyen HP, Seto NOL, Brade L, Kosma P, Brade H, Evans SV. (2001). Crystallization and preliminary X-ray diffraction analysis of two homologous antigen-binding fragments in complex with different carbohydrate antigens. Acta Crystallogr Sect D Biol Crystallogr 57: 1872-1876
147. Nguyen HP, Seto NO, MacKenzie CR, Brade L, Kosma P, Brade H, Evans SV. (2003). Germline antibody recognition of distinct carbohydrate epitopes. Nat Struct Biol 10: 1019-1025
148. Ni J, Song H, Wang Y, Stamatos NM, Wang LX. (2006). Toward a carbohydrate-based HIV-1 vaccine: synthesis and immunological studies of oligomannose-containing glycoconjugates. Bioconjugate Chem 17: 493-500
149. North B, Lehmann A, Dunbrack RL Jr. (2010). A new clustering of antibody CDR loop conformations. J Mol Biol 406: 228-256
150. O'Donnell IJ, Frangione B, Porter RR. (1970). The disulphide bonds of the heavy chain of rabbit immunoglobulin G. Biochem J 116: 261-268
151. Oettinger MA, Schatz DG, Gorka C, Baltimore D. (1990). RAG-1 and RAG-2, adjacent genes that synergistically activate V (D) J recombination. Science 248: 1517-1523
152. Oldstone MBA. (2005). Molecular mimicry, microbial infection, and autoimmune disease: evolution of the concept. Curr Top Microbiol Immunol 296: 1-17
153. Osborn MJ. (1963). Studies on the Gram-negative cell wall. I. Evidence for the role of 2-keto-3-deoxyoctonate in the lipopolysaccharide of Salmonella typhimurium. Proc Natl Acad Sci USA 50: 499-506
154. Ouerfelli O, Warren JD, Wilson RM, Danishefsky SJ. (2005). Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities. Expert Rev Vaccines 4: 677-685
155. Panjwani N, Zhao Z, Ahmad S, Yang Z, Jungalwala F, Baum J. (1995). Neolactoglycosphingolipids, potential mediators of corneal epithelial cell migration. J Biol Chem 270: 14015-14023
156. Paulson JC, Colley KJ. (1989). Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem 264: 17615-17618
157. Petermann ML, Pappenheimer AM Jr. (1941). The ultracentrifugal analysis of Diphtheria proteins. J Phys Chem 45: 1-9
158. Petermann ML. (1946). The splitting of human gamma globulin antibodies by papain and bromelin. J Am Chem Soc 68: 106-113
159. Pinilla C, Martin R, Gran B, Appel JR, Boggiano C, Wilson DB, Houghten RA. (1999). Exploring immunological specificity using synthetic peptide combinatorial libraries. Curr Opin Immunol 11: 193-202
160. Pirofski L, Lui R, DeShaw M, Kressel AB, Zhong Z. (1995). Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Infect Immun 63: 3005-3014
161. Podack ER, Tschopp J. (1984). Membrane attack by complement. Mol Immunol 21: 589-603
162. Poljak RJ, Amzel LM, Avey HP, Chen BL, Phizackerley RP, Saul F. (1973). Three-dimensional structure of the Fab fragment of a human immunoglobulin at 2.8 Åresolution. Proc Natl Acad Sci USA 70: 3305-3310
163. Porter RR. (1991). Structural studies of immunoglobulins. Scand J Immunol 34: 382-388
164. Quiocho FA. (1986). Carbohydrate-binding proteins: tertiary structures and protein-sugar interactions. Annu Rev Biochem 55: 287-315
165. Raetz CR. (1990). Biochemistry of endotoxins. Annu Rev Biochem 59: 129-170
166. Raetz CR, Dowhan W. (1990). Biosynthesis and function of phospholipids in Escherichia coli. J Biol Chem 265: 1235-1238
167. Raetz CR, Whitfield C. (2002). Lipopolysaccharide endotoxins. Annu Rev Biochem 71: 635-700
168. Ramsland PA, Farrugia W, Bradford TM, Mark Hogarth P, Scott AM. (2004). Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens. J Mol Biol 340: 809-818
169. Reason DC, Zhou J. (2004). Correlation of antigenic epitope and antibody gene usage in the human immune response to Streptococcus pneumoniae type 23 F capsular polysaccharide. Clin Immunol 111: 132-136
170. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, Ulmer AJ, Zähringer U, Seydel U, Di Padova F et al. (1994). Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8: 217-225
171. Rini JM, Schulze-Gahmen U, Wilson IA. (1992). Structural evidence for induced fit as a mechanism for antibody-antigen recognition. Science 255: 959-965
172. Rothen A, Landsteiner K. (1942). Serological reactions of protein films and denatured proteins. J Exp Med 76: 437-450
173. Roy R. (2004). New trends in carbohydrate-based vaccines. Drug Discov Today Technol 1: 327-336
174. Sansonetti P. (2002). Host-pathogen interactions: the seduction of molecular cross talk. Gut 50: 1112-1118
175. Schachter H, Chen S, Zhang W, Spence AM, Zhu S, Callahan JW, Mahuran DJ, Fan X, Bagshaw RD, She YM. (2002). Functional post-translational proteomics approach to study the role of N-glycans in the development of Caenorhabditis elegans. Biochem Soc Symp 69: 1-21
176. Schellekens GA, Visser H, De Jong BAW, Van Den Hoogen FHJ, Hazes JMW, Breedveld FC, Van Venrooij WJ. (2000). The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43: 155-163
177. Schmidt MA, Riley LW, Benz I. (2003). Sweet new world: glycoproteins in bacterial pathogens. Trends Microbiol 11: 554-561
178. Schnaitman CA, Klena JD. (1993). Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol Rev 57: 655-682
179. Scully NF, Shaper JH, Shur BD. (1987). Spatial and temporal expression of cell surface galactosyltransferase during mouse spermatogenesis and epididymal maturation. Dev Biol 124: 111-124
180. Senn BM, Lopez-Macias C, Kalinke U, Lamarre A, Isibasi A, Zinkernagel RM, Hengartner H. (2003). Combinatorial immunoglobulin light chain variability creates sufficient B cell diversity to mount protective antibody responses against pathogen infections. Eur J Immunol 33: 950-961
181. Shaw DR, Kirkham P, Schroeder HW Jr, Roben P, Silverman GJ. (1995). Structure-function studies of human monoclonal antibodies to pneumococcus type 3 polysaccharide. Ann N Y Acad Sci 764: 370-373
182. Sheriff S, Silverton EW, Padlan EA, Cohen GH, Smith-Gill SJ, Finzel BC, Davies DR. (1987). Three-dimensional structure of an antibody-antigen complex. Proc Natl Acad Sci USA 84: 8075-8079
183. Sherwood L. (2010). Human physiology: from cells to systems, 7th edn. Brooks/Cole, Cengage Learning, Australia/United States
184. Shirai H, Kidera A, Nakamura H. (1996). Structural classification of CDR-H3 in antibodies. FEBS Lett 399: 1-8
185. Shirai H, Kidera A, Nakamura H. (1999). H3-rules: identification of CDR-H3 structures in antibodies. FEBS Lett 455: 188-197
186. Slootstra JW, Puijk WC, Ligtvoet GJ, Langeveld JPM, Meloen RH. (1996). Structural aspects of antibody-antigen interaction revealed through small random peptide libraries. Mol Divers 1: 87-96
187. Slovin SF, Keding SJ, Ragupathi G. (2005). Carbohydrate vaccines as immunotherapy for cancer. Immunol Cell Biol 83: 418-428
188. Snapper CM, Mond JJ. (1996). Commentary: a model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J Immunol 157: 2229-2233
189. Stanfield RL, Takimoto-Kamimura M, Rini JM, Profy AT, Wilson IA. (1993). Major antigeninduced domain rearrangements in an antibody. Structure 1: 83-93
190. Stanfield RL, Wilson IA. (1994). Antigen-induced conformational changes in antibodies: a problem for structural prediction and design. Trends Biotechnol 12: 275-279
191. Stein KE. (1992). Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 165 (suppl 1): S49-52
192. Steiner LA, Fleishman JB. (2008). RR Porter and the structure of antibodies. In: Reid KBM, Sim RBS (eds.) Molecular aspects of innate and adaptive immunity. Royal Society of Chemistry, Cambridge, UK, pp 3-10
193. Storry JR, Olsson ML. (2009). The ABO blood group system revisited: a review and update. Immunohematology 25: 48-59
194. Sundberg EJ, Mariuzza RA. (2002). Molecular recognition in antibody-antigen complexes. Adv Protein Chem 61: 119-160
195. Süsskind M, Müller-Loennies S, Nimmich W, Brade H, Holst O. (1995). Structural investigation on the carbohydrate backbone of the lipopolysaccharide from Klebsiella pneumoniae rough mutant R20/O1. Carbohydr Res 269: C1-7
196. Tauber R, Reher K, Helling K, Scherer H. (2001). Complex carbohydrates - structure and function with respect to the glycoconjugate composition of the cupula of the semicircular canals. Biol Sci Space 15: 362-366
197. Tomlinson IM, Cox JP, Gherardi E, Lesk AM, Chothia C. (1995). The structural repertoire of the human V kappa domain. EMBO J 14: 4628-4638
198. Tonegawa S. (1983). Somatic generation of antibody diversity. Nature 302: 575-581
199. Trinh CH, Hemmington SD, Verhoeyen ME, Phillips SEV. (1997). Antibody fragment Fv4155 bound to two closely related steroid hormones: the structural basis of fine specificity. Structure 5: 937-948
200. Tsubata T, Wu J, Honjo T. (1993). B-cell apoptosis induced by antigen receptor crosslinking is blocked by a T-cell signal through CD40. Nature 364: 645-648
201. van Den Elsen J, Vandeputte-Rutten L, Kroon J, Gros P. (1999). Bactericidal antibody recognition of meningococcal PorA by induced fit. J Biol Chem 274: 1495-1501
202. van Ree R. (2000). Carbohydrate epitopes and their relevance for the diagnosis and treatment of allergic diseases. Int Arch Allergy Immunol 129: 189-197
203. van Roon AMM, Pannu NS, De Vrind JPM, van Der Marel GA, van Boom JH, Hokke CH, Deelder AM, Abrahams JP. (2004). Structure of an anti-Lewis X Fab fragment in complex with its Lewis X antigen. Structure 12: 1227-1236
204. Vargas Madrazo E, Paz GE. (2002). Modifications to canonical structure sequence patterns: analysis for L1 and L3. Proteins: Struct, Funct, Bioinform 47: 250-254
205. Vliegenthart JF. (2006). Carbohydrate based vaccines. FEBS Lett 580: 2945-2950
206. Vollmers HP, Brändlein S. (2007). Natural antibodies and cancer. J Autoimmun 29: 295-302
207. Vos Q, Lees A, Wu ZQ, Snapper CM, Mond JJ. (2000). B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 176: 154-170
208. Vyas NK, Vyas MN, Chervenak MC, Johnson MA, Pinto BM, Bundle DR, Quiocho FA. (2002). Molecular recognition of oligosaccharide epitopes by a monoclonal Fab specific for Shigella flexneri Y lipopolysaccharide: X-ray structures and thermodynamics. Biochemistry 41: 13575-13586
209. Webster DM, Henry AH, Rees AR. (1994). Antibody-antigen interactions. Curr Opin Struct Biol 4: 123-129
210. Wedemayer GJ, Patten PA, Wang LH, Schultz PG, Stevens RC. (1997). Structural insights into the evolution of an antibody combining site. Science 276: 1665-1669
211. Wilson IA, Stanfield RL, Rini JM, Arevalo JH, Schulze-Gahmen U, Fremont DH, Stura EA. (1991). Structural aspects of antibodies and antibody-antigen complexes. Ciba Found Symp 159: 13-28
212. Xu JL, Davis MM. (2000). Diversity in the CDR3 region of V (H) is sufficient for most antibody specificities. Immunity 13: 37-45
213. Yoshida-Noro C, Heasman J, Goldstone K, Vickers L, Wylie C. (1999). Expression of the Lewis groupcarbohydrate antigens during Xenopus development. Glycobiology 9: 1323-1330
214. Zhao YY, Takahashi M, Gu JG, Miyoshi E, Matsumoto A, Kitazume S, Taniguchi N. (2008). Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci 99: 1304-1310
215. Zhou J, Lottenbach KR, Barenkamp SJ, Lucas AH, Reason DC. (2002). Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23 F. Infect Immun 70: 4083-4091
216. Zhou J, Lottenbach KR, Barenkamp SJ, Reason DC. (2004). Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B. Infect Immun 72: 3505-3514